VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $429 | -35.5% | 38,712 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $665 | -59.7% | 41,038 | -58.6% | 0.00% | -50.0% |
| Q1 2023 | $1,651 | +65.1% | 99,185 | +21843.6% | 0.00% | – |
| Q2 2022 | $1,000 | -99.4% | 452 | -99.2% | 0.00% | – |
| Q1 2022 | $177,000 | +6.0% | 59,104 | +62.9% | 0.00% | – |
| Q4 2021 | $167,000 | -90.7% | 36,276 | -87.4% | 0.00% | -100.0% |
| Q3 2021 | $1,803,000 | -0.4% | 287,173 | -5.0% | 0.00% | 0.0% |
| Q2 2021 | $1,810,000 | -5.1% | 302,142 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $1,908,000 | +12.4% | 301,597 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,698,000 | -3.2% | 301,597 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,755,000 | -19.3% | 301,597 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $2,175,000 | +54.1% | 301,597 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $1,411,000 | -41.7% | 301,597 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $2,419,000 | +10.8% | 301,597 | -4.9% | 0.00% | 0.0% |
| Q3 2019 | $2,183,000 | -24.2% | 317,297 | -8.6% | 0.00% | -25.0% |
| Q2 2019 | $2,881,000 | -12.5% | 347,089 | +4.8% | 0.00% | 0.0% |
| Q1 2019 | $3,291,000 | +27.9% | 331,089 | -1.6% | 0.00% | 0.0% |
| Q4 2018 | $2,573,000 | +59.7% | 336,377 | +263.7% | 0.00% | +100.0% |
| Q3 2018 | $1,611,000 | +133.1% | 92,480 | +27.0% | 0.00% | +100.0% |
| Q2 2018 | $691,000 | – | 72,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |